Rallybio
RLYB
53 hedge funds and large institutions have $183M invested in Rallybio in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 7 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.36% less ownership
Funds ownership: 10.91% → 10.54% (-0.36%)
7% less funds holding
Funds holding: 57 → 53 (-4)
14% less capital invested
Capital invested by funds: $212M → $183M (-$28.7M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$418K |
| 2 |
CA
CHI Advisors
New York
|
+$222K |
| 3 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$194K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
| 5 |
JP Morgan Chase
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$646K |
| 2 |
CCM
CAAS Capital Management
New York
|
-$629K |
| 3 |
Walleye Capital
New York
|
-$526K |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$439K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$167K |
RLYB Hedge Fund Activity: Q1 2023 in Review
53 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q1 2023, worth a combined $183M — down 14% from $212M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of RLYB and 3 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 19 added.
The largest buyer was Geode Capital Management, adding an estimated $418K. The largest seller was 5AM Venture Management, cutting an estimated $646K.
- 53 institutional investors held Rallybio (RLYB) as of Q1 2023, down from 57 in Q4 2022.
- Funds reported $183M of Rallybio stock for Q1 2023, down 14% quarter-over-quarter.
- 3 funds opened new Rallybio positions in Q1 2023 and 7 closed out, a net change of -4 holders.
- The largest Rallybio buyer in Q1 2023 was Geode Capital Management, an estimated $418K added.
- The largest Rallybio seller in Q1 2023 was 5AM Venture Management, an estimated $646K sold.
Based on aggregated 13F filings for Q1 2023.